PDB46 Cost-Effectiveness of Angiotensin Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in the Netherlands - A Markov Model
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.1349
https://www.valueinhealthjournal.com/article/S1098-3015(11)02911-1/fulltext
Section Title :
Diabetes/Endocrine Disorders
Section Order :
1304
First Page :
A480
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02911-1&doi=10.1016/j.jval.2011.08.1349